FindTrial
Sign In

To explore a mode of two-way referral systems for patients with chronic HBV infection in the context of expanding the indications for antiviral therapy

To explore a mode of two-way referral systems for patients with chronic HBV infection in the context of expanding the indications for antiviral therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500104878
Enrollment
Unknown
Registered
2025-06-25
Start date
2025-07-01
Completion date
Unknown
Last updated
2025-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Hepatitis B

Interventions

Treatment group:None
Control group:None

Sponsors

Beijing Ditan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Age: > 30 years old; (2) Serum HBsAg positive, HBeAg positive or negative, HBV DNA positive; (3) not currently receiving antiviral therapy with interferon and/or nucleos(t)ide analogues; (4) Liver function: ALT and AST were in the normal range; (5) Agree to join this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients with chronic hepatitis B who are on antiviral therapy; (2) Patients with liver cirrhosis, liver cancer and liver failure; (3) Patients with other systemic tumors; (4) Patients who refuse to sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
Criteria for two-way referral for chronic hepatitis B;—

Secondary

MeasureTime frame
The rate of two-way referral and the rate of antiviral treatment;—

Countries

China

Contacts

Public ContactGao Xuesong

No. 8, Jingshun East Street, Chaoyang District, Beijing

gaoxuesong@ccmu.edu.cn+86 137 1868 9825

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026